Whalegun
Home

Sanofi SNY paid Forbes-Tate $50K for lobbying in Q4 2022 · Medicare, Taxation and 1 more issue

Trade details

Type
Lobbying report
Amount
$50,000
Quarter
Q4 2022
Stock
Sanofi SNY
Client
Sanofi U.S.
Reported
23/01/16

$100K on lobbying in 2022

What else happened in Sanofi around then

Filed or reported within 30 days of the trade day · 22/12/01~23/01/30

Sanofi U.S.'s other lobbying reports

  • Sanofi U.S.

    LobbyingSanofi

    $50K

    Reported 07/20

  • Sanofi U.S.

    LobbyingSanofi

    $50K

    Reported 07/20

  • Sanofi U.S.

    LobbyingSanofi

    $50K

    Reported 04/20

  • Sanofi U.S.

    LobbyingSanofi

    $50K

    Reported 04/19

  • Sanofi U.S.

    LobbyingSanofi

    $50K

    Reported 01/20

Sanofi SNY paid Forbes-Tate $50K for lobbying in Q4 2022 · Medicare, Taxation and 1 more issue | Whalegun